Opal reagent packs
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 36C24122D0031
- Awardee
-
Akoya Biosciences, Inc. UEI NHN4QEBQTJT3
- Awarding agency
-
Veterans Integrated Service Network 1
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 6 $139,201 obligated
Award facts
- Combined order value
- $139,201 Current and potential, with all options
- Last date to order 82% complete
- IDV ceiling 62% used
- $225,725.00
- Maximum order
- $70,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Contracting staff
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
Award details come from SAM.gov/FPDS.
About this IDV
Akoya Biosciences, Inc., doing business as Phenoptics, was awarded a single-award Indefinite Delivery Vehicle (IDV) contract by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 1 (VISN 1) with a ceiling value of $225,725 and an ultimate completion date of September 27, 2027. The contract, awarded on September 28, 2022, establishes a firm fixed-price vehicle for the procurement of OPAL reagent packs—specialized diagnostic reagents used in medical imaging and pathology applications to support veteran healthcare operations. OPAL reagents are consumable materials essential for tissue staining and preparation in advanced imaging protocols, enabling diagnostic testing and research capabilities across VA medical facilities within VISN 1. The contract contains no socioeconomic set-asides and is performed primarily from Marlborough, Massachusetts, where Akoya's manufacturing and fulfillment operations are based.
Under this IDV, the VA has issued five delivery orders totaling approximately $125,192.25 in contract value through March 2026, reflecting active utilization of the vehicle to support ongoing diagnostic and laboratory operations. Delivery orders have ranged from $14,446 to $40,000, with completion dates extending from October 2023 through March 2026, demonstrating sustained demand for OPAL reagent packs across VISN 1 healthcare facilities. As a self-certified small disadvantaged business and manufacturer, Akoya has successfully leveraged this IDV relationship to provide consistent supply chain support for the VA's medical imaging and diagnostic capabilities, enabling efficient procurement of critical reagents without requiring individual competitive solicitations for each purchase requirement.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 36C24122D0031?
36C24122D0031 was awarded to Akoya Biosciences, Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on September 28, 2022.
How much is contract 36C24122D0031 worth?
Orders under 36C24122D0031 have obligated $139,201. 36C24122D0031's own ceiling is $225,725. A single order can be worth up to $70,000.
How many orders have been placed under contract 36C24122D0031?
6 orders have been placed under 36C24122D0031, the latest on August 1, 2026.
Who can order from contract 36C24122D0031?
36C24122D0031 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 36C24122D0031 competed?
The extent of competition for 36C24122D0031 was not competed. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV